Viewing Study NCT05670951


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2025-12-25 @ 9:53 PM
Study NCT ID: NCT05670951
Status: RECRUITING
Last Update Posted: 2025-05-28
First Post: 2023-01-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants
Sponsor: Elgan Pharma Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module